PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine ...

MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...

Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...

Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.

Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support - and the more information included in AI prompting, the better its performance. This ...

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...

A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...

A new study reveals that gut bacteria and metabolites may hold the key to detecting serious digestive diseases earlier and more easily. Using AI, scientists found that biomarkers linked to one ...

Quest's Infrastructure to Enable Access to HelioLiver(TM) , an AI-Powered, Blood-Based Test for Early Detection of Liver Cancer IRVINE, Calif., March 18, 2026 /PRNewswire/ -- Helio Genomics, an ...

New cfDNA test enables multicancer detection with high accuracy, offering a cost effective approach for early diagnosis and screening.